13 May

WASHINGTON (May 13, 2019) — The George Washington University (GW) Cancer Center is pleased to announce the establishment of the Dr. Cyrus Katzen Family Director of the GW Cancer Center, thanks to a generous gift from GW alumnus and former Board of Trustee member, ...


27 Mar

WASHINGTON (March 27, 2019) – Principal Investigator Mandi Pratt-Chapman, MA has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention (CDC) to provide comprehensive technical assistance for National Comprehensive Cancer Control...


18 Mar

The George Washington University (GW) Cancer Center is pleased to announce that accomplished medical oncologist George Kim, MD, has joined the GW Cancer Center. He will serve as the director of the Gastrointestinal Cancers Program at the GW Cancer Center.


15 Mar

A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.


26 Feb

A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).


22 Feb

The George Washington University (GW) Cancer Center is pleased to announce the expansion of the Cutaneous Oncology Multidisciplinary Program. The program will bring together dermatologists, dermatologic surgeons, medical, surgical and radiation oncologists, and pathologists to provide personalized skin cancer care to patients in the District and surrounding region.


13 Feb

A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.


28 Jan

WASHINGTON (Jan. 28, 2018) — A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer. The goal of this nanoimmunotherapy combination is to increase the potency of immune...


16 Jan

The George Washington University (GW) Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center...


31 Oct

WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by...


01 Oct

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.


27 Sep

WASHINGTON (Sept. 26, 2018) – Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the George Washington University (GW) School of Medicine and Health Sciences. He will also serve as a professor in the...


05 Sep

A study led by Paul Brindley, PhD, is looking at the cellular link between liver fluke and cholangiocarcinoma.


27 Aug

Katherine Chiappinelli, PhD, was awarded a prestigious grant from The G. Harold and Leila Y. Mathers Foundation.


23 Aug

A team at the GW Cancer Center will study the role of the COMPASS complex in the initiation and progression of pancreatic cancer.